Literature DB >> 2201722

Immediate and overnight effects of zopiclone 7.5 mg and nitrazepam 5 mg with ethanol, on psychomotor performance and memory in healthy volunteers.

I Hindmarch1.   

Abstract

The effects of ethanol (0.2-0.4 g/kg) taken in conjunction with a single nocturnal dose of zopiclone 7.5 mg or nitrazepam 5 mg, on the early morning performance were investigated by means of psychomotor tests in 9 female volunteers. While there was no noticeable difference in the Choice Reaction Time (CRT) for any of the drug-ethanol combinations and ethanol alone, the zopiclone combination appeared to be initially more sedative in the Critical Flicker Fusion test (CFF). Both drug combinations impaired short-term memory and induced retrograde amnesia to the same extent, although only the nitrazepam-ethanol treatment caused further anterograde amnesia as compared to ethanol alone. Finally, both drug-ethanol combinations exhibited equivalent hypnotic properties as assessed by the Leeds Sleep Evaluation Questionnaire (LSEQ) without any more residual effects than with ethanol alone. These results suggest neither zopiclone, nor nitrazepam potentiate the effects of ethanol at the doses used.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2201722

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  4 in total

Review 1.  Information processing and accidental injuries.

Authors:  S Taimela
Journal:  Sports Med       Date:  1992-12       Impact factor: 11.136

Review 2.  Low blood alcohol concentrations and driving impairment. A review of experimental studies and international legislation.

Authors:  S D Ferrara; S Zancaner; R Giorgetti
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

Review 3.  Zopiclone. A review of its pharmacological properties and therapeutic efficacy as an hypnotic.

Authors:  A N Wadworth; D McTavish
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

4.  Eszopiclone: its use in the treatment of insomnia.

Authors:  Jaime M Monti; S R Pandi-Perumal
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.